MOLIT at GMDS 2025: Use of Health Data
The MOLIT Data Science & AI team participated in the GMDS in Jena from September 7–10, 2025, presenting several contributions on the topic of “Use of health data”…
Together to the finish line: MOLIT & MSG at the Stimme Firmenlauf
Together as a team, eight motivated runners from MOLIT and MSG took on the 2025 STIMME Firmenlauf…
Interdisciplinary Dialogue on AI-Supported Patient Care
At a meeting of high-level representatives from ETH Zurich, University Hospital Zurich, the Max Planck Institute, SLK Clinics, the MOLIT Institute, and Heilbronn University, the focus was on the future of personalized medicine…
Knowledge exchange at the FHIR DevDays
The MOLIT Institute and MOLIT Service GmbH (MSG) at the FHIR DevDays – a leading forum for the development and application of the FHIR standard…
Heilbronn as an Innovation Hub: Launch of the I³-Lab
On September 10, the official launch of the I³-Lab in Heilbronn took place with the symbolic handover of the funding check…
MOLIT at the 6th Anniversary of the EMBL | Stanford Life Science Alliance in Heilbronn
At the EMBL | Stanford Life Science Alliance meeting, Martin Jechlinger presented how living bioprobes are opening up new paths in personalized cancer therapy…
MOLIT at GMDS 2023 in Heilbronn
The MOLIT Institute participated in the annual conference of the German Association for Medical Informatics, Biometry and Epidemiology (GMDS)…
Frauenselbsthilfe (FSH) visits MOLIT
Around 70 guests from various groups of the Baden-Württemberg / Bavaria regional association of Frauenselbsthilfe Krebs (FSH) visited the MOLIT Institute…
MOLIT visits Fundación Arturo López Pérez (FALP)
To establish contacts and initiate collaborative projects, representatives of the MOLIT Institute for Personalized Medicine visited the Fundación Arturo López Pérez (FALP) in Santiago de Chile…
Symposium on Therapy Management Through Apps
At the symposium on mobile health applications in the therapy management of chronic diseases, current developments were presented and discussed…